Sai Life Sciences IPO Allotment: Your Guide to Checking Status on NSE & BSE

For sophisticated investors and financial advisors navigating the complexities of the capital markets, understanding the nuances of IPO allotment is crucial for strategic portfolio management. The Sai Life Sciences Limited IPO, a significant offering in the pharmaceutical research and development sector, has generated considerable interest. This guide provides a clear, data-driven approach to verifying your allotment status, empowering you with timely information for informed decision-making.

Understanding the Sai Life Sciences IPO

The Sai Life Sciences IPO was structured as a book-built issue, aiming to raise ₹3,042.62 crores. The offering comprised a fresh issue of 1.73 crore shares (₹950.00 crores) and an offer for sale of 3.81 crore shares (₹2,092.62 crores). The subscription period ran from December 11 to December 13, 2025, with the share allotment anticipated around December 16, 2025, and a tentative listing date of December 18, 2025, on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

The price band for the IPO was set between ₹522 to ₹549 per share. Analyzing subscription levels provides insight into market sentiment:

• Overall Subscription: The IPO closed with a subscription rate of 10.27 times.
• Qualified Institutional Buyers (QIBs): Demonstrated strong conviction, subscribing 29.78 times their allocated portion.
• Non-Institutional Investors (NIIs): Showed robust interest, subscribing 4.99 times.
• Retail Investors: Participated actively, with subscriptions reaching 1.39 times their quota.

These figures underscore the demand for quality assets within the pharmaceutical R&D space.

How to Verify Your Sai Life Sciences IPO Allotment Status

Accessing your allotment status promptly is key to planning your next investment steps. PortoAI's platform emphasizes real-time data synthesis, enabling you to act swiftly. Here's how you can check your status through the primary channels:

Checking Allotment Status on BSE

1. Navigate to the official BSE website.
2. Under "Issue Type," select "Equity."
3. From the "Issue Name" dropdown, choose "Sai Life Sciences Limited."
4. Enter your unique application number.
5. Provide your Permanent Account Number (PAN) card ID.
6. Complete the security check and click "Search."

Checking Allotment Status on NSE

1. Visit the NSE IPO allotment page.
2. New users will need to sign up; existing users can log in.
3. Input the required details, such as your application number or PAN.
4. Click on "Get Data" to retrieve your allotment status.

Checking Allotment Status via Kfin Technologies India (Registrar)

Kfin Technologies India acts as the IPO registrar, providing a direct channel for status verification:

1. Go to the Kfin Technologies IPO website.
2. Select "Sai Life Sciences" from the "Select IPO" dropdown menu.
3. Choose your verification method: Application No., Portfolio, or PAN.
4. Enter the requested details based on your selected method.
5. Complete the Captcha and click "Submit." Your allotment status will be displayed.

Sai Life Sciences: A Business Overview

Founded in 1999, Sai Life Sciences operates at the forefront of small-molecule new chemical entity (NCE) research, development, and manufacturing. The company serves a global clientele of biotech and pharmaceutical firms, offering tailored solutions across the drug discovery and development lifecycle. As of September 30, 2025, Sai Life Sciences had established partnerships with over 280 pharmaceutical innovators, including 18 of the top 25 global pharmaceutical companies by revenue. Their market reach extends across the United States, the United Kingdom, Europe, and Japan, underscoring their international presence and expertise.

Strategic Use of IPO Proceeds

The company intends to allocate the Net Proceeds from this IPO towards two primary strategic objectives:

• Debt Reduction: Repaying or prepaying outstanding borrowings, thereby strengthening the balance sheet and improving financial leverage.
• General Corporate Purposes: Funding ongoing operational needs and strategic initiatives, ensuring continued growth and market competitiveness.

Empowering Investment Decisions with PortoAI

In today's dynamic financial landscape, timely access to accurate data is paramount. Tools like the PortoAI Market Lens can help investors track IPO performance and market sentiment in real-time. By synthesizing vast amounts of financial data, PortoAI empowers sophisticated investors to make more confident, data-driven decisions, whether evaluating new offerings or managing existing portfolios. Our risk console further assists in assessing the potential impact of new investments on your overall portfolio risk profile.

Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice. Investing in securities involves risks, including the potential loss of principal. Always conduct your own due diligence or consult with a qualified financial advisor.